Gagnon Suzanne 4
4 · Sun BioPharma, Inc. · Filed May 23, 2019
Insider Transaction Report
Form 4
Gagnon Suzanne
DirectorChief Medical Officer
Transactions
- Award
Employee Stock Option (right to buy)
2019-05-21+84,100→ 84,100 totalExercise: $2.95Exp: 2029-05-21→ Common Stock (84,100 underlying) - Award
Employee Stock Option (right to buy)
2019-05-21+40,300→ 40,300 totalExercise: $2.95From: 2019-05-21Exp: 2029-05-21→ Common Stock (40,300 underlying)
Footnotes (1)
- [F1]Immediately exercisable as to 25% of the shares and scheduled to vest with respect to 25% of the shares on each of May 21, 2020, May 21, 2021 and May 21, 2022.